These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24982238)

  • 1. Inhibitory action of levocetirizine on the production of eosinophil chemoattractants RANTES and eotaxin in vitro and in vivo.
    Kanei A; Asano K; Kanai K; Furuta A; Sasaki K; Suzaki H
    In Vivo; 2014; 28(4):657-66. PubMed ID: 24982238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive activity of quercetin on the production of eosinophil chemoattractants from eosinophils in vitro.
    Sakai-Kashiwabara M; Abe S; Asano K
    In Vivo; 2014; 28(4):515-22. PubMed ID: 24982217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
    Maiti R; Rahman J; Jaida J; Allala U; Palani A
    Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):796-800. PubMed ID: 20713756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells.
    Thomson L; Blaylock MG; Sexton DW; Campbell A; Walsh GM
    Clin Exp Allergy; 2002 Aug; 32(8):1187-92. PubMed ID: 12190657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa.
    Terada N; Hamano N; Kim WJ; Hirai K; Nakajima T; Yamada H; Kawasaki H; Yamashita T; Kishi H; Nomura T; Numata T; Yoshie O; Konno A
    Am J Respir Crit Care Med; 2001 Aug; 164(4):575-9. PubMed ID: 11520718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive Activity of Quercetin on Periostin Functions In Vitro.
    Irie S; Kashiwabara M; Yamada A; Asano K
    In Vivo; 2016; 30(1):17-25. PubMed ID: 26709124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of clara cell 10-kD protein (CC10) production from nasal epithelial cells by fexofenadine hydrochloride.
    Nogaki T; Asano K; Furuta A; Kanai K; Suzaki I; Kanei A; Suzaki H
    Asian Pac J Allergy Immunol; 2012 Jun; 30(2):139-45. PubMed ID: 22830293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levocetirizine and cytokine production and apoptosis of human eosinophils.
    Hasala H; Janka-Junttila M; Moilanen E; Kankaanranta H
    Allergy Asthma Proc; 2007; 28(5):582-91. PubMed ID: 18034979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive activity of epinastine hydrochloride on eosinophil activation in vitro.
    Mochizuki Y; Furuta A; Furuya A; Kanai K; Asano K; Suzaki H
    In Vivo; 2008; 22(1):13-20. PubMed ID: 18396776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive activity of fexofenadine hydrochloride on the production of eosinophil chemoattractants from human nasal fibroblasts in vitro.
    Asano K; Kanai K; Suzaki H
    Arzneimittelforschung; 2004; 54(8):436-43. PubMed ID: 15460210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.
    Yoshifuku K; Matsune S; Ohori J; Sagara Y; Fukuiwa T; Kurono Y
    Rhinology; 2007 Sep; 45(3):235-41. PubMed ID: 17956026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
    Shin SH; Park JY; Jeon CH; Choi JK; Lee SH
    Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans.
    Menzies-Gow A; Ying S; Phipps S; Kay AB
    Clin Exp Allergy; 2004 Aug; 34(8):1276-82. PubMed ID: 15298570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis.
    Lee CF; Sun HL; Lu KH; Ku MS; Lue KH
    Pediatr Allergy Immunol; 2009 Aug; 20(5):493-9. PubMed ID: 19175892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA
    Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levocetirizine modulates lymphocyte activation in patients with allergic rhinitis.
    Mahmoud F; Arifhodzic N; Haines D; Novotney L
    J Pharmacol Sci; 2008 Oct; 108(2):149-56. PubMed ID: 18946193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative expression levels of regulated on activation, normal T cell expressed and secreted and eotaxin transcripts in toluene diisocyanate-induced allergic rats.
    Im GJ; Hwang CS; Jung HH
    Acta Otolaryngol; 2005 Apr; 125(4):370-7. PubMed ID: 15823807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
    Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.